2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Abstract
BACKGROUND:
The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, nutrition, sleep, and obesity) and health factors (cholesterol, blood pressure, glucose control, and metabolic syndrome) that contribute to cardiovascular health. The AHA Heart Disease and Stroke Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, brain health, complications of pregnancy, kidney disease, congenital heart disease, rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coronary heart disease, cardiomyopathy, heart failure, valvular disease, venous thromboembolism, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs).
METHODS:
The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing. The 2025 AHA Statistical Update is the product of a full year’s worth of effort in 2024 by dedicated volunteer clinicians and scientists, committed government professionals, and AHA staff members. This year’s edition includes a continued focus on health equity across several key domains and enhanced global data that reflect improved methods and incorporation of ≈3000 new data sources since last year’s Statistical Update.
RESULTS:
Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics.
CONCLUSIONS:
The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.
Formats available
You can view the full content in the following formats:
Supplemental Material
File (global cvd statistics supplement.pdf)
- Download
- 1.24 MB
File (central europe eastern europe and central asia cvd statistics supplement.pdf)
- Download
- 781.69 KB
File (high-income countries cvd statistics supplement.pdf)
- Download
- 937.20 KB
File (latin america and caribbean cvd statistics supplement.pdf)
- Download
- 444.69 KB
File (north africa and middle east cvd statistics supplement.pdf)
- Download
- 689.22 KB
File (south asia cvd statistics supplement.pdf)
- Download
- 523.38 KB
File (southeast asia east asia and oceania cvd statistics supplement.pdf)
- Download
- 616.79 KB
File (sub-saharan africa cvd statistics supplement.pdf)
- Download
- 625.25 KB
Information & Authors
Information
Published In
Copyright
© 2025 American Heart Association, Inc. free
Versions
You are viewing the most recent version of this article.
History
Published online: 27 January 2025
Keywords
Subjects
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.